We also found that blocking either the PERK pathway or IFNγ inhibited PD-L1 upregulation and that PD-L1 expression on MDS cells did not inhibit their lysis by tumor-specific T cells. The gene discussed is IFNG; the disease is myelodysplastic syndrome.